Literature DB >> 18709448

Flocculated amorphous nanoparticles for highly supersaturated solutions.

Michal E Matteucci1, Joseph C Paguio, Maria A Miller, Robert O Williams Iii, Keith P Johnston.   

Abstract

PURPOSE: To recover polymer-stabilized amorphous nanoparticles from aqueous dispersions efficiently by salt flocculation and to show that the particles redisperse and dissolve rapidly to produce highly supersaturated solutions.
METHODS: Nanoparticle dispersions of itraconazole stabilized by nonionic polymers were formed by antisolvent precipitation and immediately flocculated with sodium sulfate, filtered and dried. The size after redispersion in water, crystallinity, and morphology were compared with those for particles produced by spray drying and rapid freezing.
RESULTS: Particle drug loading increased to approximately 90% after salt flocculation and removal of excess polymer with the filtrate. The formation of the flocs at constant particle volume fraction led to low fractal dimensions (open flocs), which facilitated redispersion in water to the original primary particle size of approximately 300 nm. Amorphous particles, which were preserved throughout the flocculation-filtration-drying process, dissolved to supersaturation levels of up to 14 in pH 6.8 media. In contrast, both spray dried and rapidly frozen nanoparticle dispersions crystallized and did not produce submicron particle dispersions upon addition to water, nor high supersaturation values.
CONCLUSIONS: Salt flocculation produces large yields of high surface area amorphous nanoparticle powders that de-aggregate and dissolve rapidly upon redispersion in pH 6.8 media, for supersaturation levels up to 14.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18709448     DOI: 10.1007/s11095-008-9659-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

1.  Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers.

Authors:  Yucun Zhu; Navnit H Shah; A Waseem Malick; Martin H Infeld; James W McGinity
Journal:  Drug Dev Ind Pharm       Date:  2006-06       Impact factor: 3.225

2.  Permeation enhancement of ketoprofen using a supersaturated system with antinucleant polymers.

Authors:  Usanee Kumprakob; Junichi Kawakami; Isao Adachi
Journal:  Biol Pharm Bull       Date:  2005-09       Impact factor: 2.233

3.  Physical properties of solid dispersions of poorly water-soluble drugs with enteric coating agents.

Authors:  A Hasegawa; R Kawamura; H Nakagawa; I Sugimoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-08       Impact factor: 1.645

4.  Membrane transport of hydrocortisone acetate from supersaturated solutions; the role of polymers.

Authors:  S L Raghavan; B Kiepfer; A F Davis; S G Kazarian; J Hadgraft
Journal:  Int J Pharm       Date:  2001-06-19       Impact factor: 5.875

5.  Comparison of nicotinamide, ethylurea and polyethylene glycol as carriers for nifedipine solid dispersion systems.

Authors:  H Suzuki; H Sunada
Journal:  Chem Pharm Bull (Tokyo)       Date:  1997-10       Impact factor: 1.645

6.  Nifedipine solid dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blend for controlled drug delivery. Effect of drug loading on release kinetics.

Authors:  Jingjun Huang; Rodney J Wigent; Catherine M Bentzley; Joseph B Schwartz
Journal:  Int J Pharm       Date:  2006-04-25       Impact factor: 5.875

7.  Stable amorphous danazol nanostructured powders with rapid dissolution rates produced by spray freezing into liquid.

Authors:  Jiahui Hu; Keith P Johnston; Robert O Williams
Journal:  Drug Dev Ind Pharm       Date:  2004-08       Impact factor: 3.225

8.  Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility.

Authors:  Piyush Gupta; Garima Chawla; Arvind K Bansal
Journal:  Mol Pharm       Date:  2004 Nov-Dec       Impact factor: 4.939

9.  Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion, Part II.

Authors:  Karel Six; Hugo Berghmans; Christian Leuner; Jennifer Dressman; Kristof Van Werde; Jules Mullens; Luc Benoist; Mireille Thimon; Laurent Meublat; Geert Verreck; Jef Peeters; Marcus Brewster; Guy Van den Mooter
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

10.  Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion--Part I.

Authors:  Geert Verreck; Karel Six; Guy Van den Mooter; Lieven Baert; Jef Peeters; Marcus E Brewster
Journal:  Int J Pharm       Date:  2003-01-30       Impact factor: 5.875

View more
  5 in total

1.  Enhancement of cellular uptake, transport and oral absorption of protease inhibitor saquinavir by nanocrystal formulation.

Authors:  Yuan He; Deng-ning Xia; Qiu-xia Li; Jin-song Tao; Yong Gan; Chi Wang
Journal:  Acta Pharmacol Sin       Date:  2015-08-10       Impact factor: 6.150

2.  A novel domperidone hydrogel: preparation, characterization, pharmacokinetic, and pharmacodynamic properties.

Authors:  Chun-Hui Zhang; Bing-Xiang Zhao; Yue Huang; Ying Wang; Xi-Yu Ke; Bo-Jun Zhao; Xuan Zhang; Qiang Zhang
Journal:  J Drug Deliv       Date:  2011-02-20

3.  Design and Solidification of Fast-Releasing Clofazimine Nanoparticles for Treatment of Cryptosporidiosis.

Authors:  Yingyue Zhang; Jie Feng; Simon A McManus; Hoang D Lu; Kurt D Ristroph; Eugene J Cho; Ellen L Dobrijevic; Hak-Kim Chan; Robert K Prud'homme
Journal:  Mol Pharm       Date:  2017-09-20       Impact factor: 4.939

4.  Rapid Recovery of Clofazimine-Loaded Nanoparticles with Long-Term Storage Stability as Anti-Cryptosporidium Therapy.

Authors:  Jie Feng; Yingyue Zhang; Simon A McManus; Kurt D Ristroph; Hoang D Lu; Kai Gong; Claire E White; Robert K Prud'homme
Journal:  ACS Appl Nano Mater       Date:  2018-04-20

5.  Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale.

Authors:  Jie Feng; Chester E Markwalter; Chang Tian; Madeleine Armstrong; Robert K Prud'homme
Journal:  J Transl Med       Date:  2019-06-14       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.